Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-02-07
1997-11-18
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514255, 514272, 514324, 514333, 546194, 5462764, 5462811, 544224, 544333, 544405, A61K 3150, A61K 31505, C07D40914
Patent
active
056887965
ABSTRACT:
The present invention provides class of compounds of formula I ##STR1## and their pharmaceutically acceptable salts in which R.sup.1 is hydrogen, hydroxy, alkoxy, alkoxycarbonyloxy, alkylcarbonyloxy, arylcarbonyloxy; R.sup.2 is hydrogen, hydroxy, alkoxy, alkoxycarbonyloxy, alkylcarbonyloxy, alkylsulfonyloxy, arylcarbonyloxy, Cl or Br; R.sup.3 and R.sup.4 are independently C.sub.1 -C.sub.4 alkyl, or combine with the nitrogen atom to which they are attached to form a pyrrolidino, piperidino, or hexamethyleneimino ring; X is selected from ##STR2## and Y is --CO--, --CHOH--, or --CH.sub.2 --. The compounds and pharmaceutical compositions containing the compounds, either alone or in combination with either progestin or estrogen, are useful for alleviating the symptoms of osteoporosis, cardiovascular related pathological conditions such as hyperlipidemia, and estrogen-dependent cancer.
The compounds of the present invention also are useful for inhibiting uterine fibroid disease and endometriosis in women and aortal smooth muscle cell proliferation, particularly restenosis, in humans.
REFERENCES:
patent: 3293263 (1966-12-01), Lednicer
patent: 3320271 (1967-05-01), Lednicer
patent: 3862232 (1975-01-01), Lednicer
patent: 4133814 (1979-01-01), Jones et al.
patent: 4358593 (1982-11-01), Jones et al.
patent: 4380635 (1983-04-01), Peter
patent: 4418068 (1983-11-01), Jones
patent: 5470854 (1995-11-01), von Angerer et al.
patent: 5472962 (1995-12-01), Koizumi et al.
patent: 5482949 (1996-01-01), Black et al.
patent: 5510357 (1996-04-01), Palkowitz
Jones, et al., J. Med. Chem., 35: 931-938 (1992).
Crenshaw, et al., J. Med. Chem., 14: 185-1190 (1971).
Lednicer, et al., J. Med. Chem. 8:52-57 (1964).
Cullinan George Joseph
Fahey Kennan Joseph
Boone David E.
Eli Lilly and Company
Janssen Jerry F.
McKane Joseph
LandOfFree
Heterocyclic substituted benzothiophenes, compositions, and meth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic substituted benzothiophenes, compositions, and meth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic substituted benzothiophenes, compositions, and meth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1565857